Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Not Confirmed
Not Confirmed
31 July-02 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Industry Trade Show
Not Confirmed
31 July-02 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
30 Jul 2025
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/jj-legend-crunch-multiple-myeloma-numbers-1st-carvykti-tv-ad
30 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250730478546/en/Johnson-Johnson-to-Participate-in-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference
29 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/johnson--johnson-files-with-us-fda-to-include-new-evidence-in-tremfya-guselkumab-label-as-the-only-il-23-inhibitor-to-demonstrate-significant-inhibition-of-joint-structural-damage-in-active-psoriatic-arthritis-302516055.html
29 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250729974759/en/Boston-Jury-Hits-Johnson-Johnson-with-Record-%2442M-Verdict-in-Asbestos-Baby-Powder-Case
24 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250724655759/en/Johnson-Johnson-to-Participate-in-the-2025-Wells-Fargo-Healthcare-Conference
18 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/johnson--johnson-receives-us-fda-priority-review-for-tar-200-nda-in-high-risk-non-muscle-invasive-bladder-cancer-302507112.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Johnson & Johnson is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Nicotine bulk with DMF offered by Johnson & Johnson
Find a price of Naloxone Hydrochloride bulk offered by Johnson & Johnson
Find a price of Sodium Hyaluronate bulk offered by Johnson & Johnson